Victory Capital Management Inc Liquidia Corp Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$4.86 - $11.44 $7,605 - $17,903	-1,565 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$3.31 - $7.15 $1,929 - $4,168	-583 Reduced 27.14%	1,565 $7,000
Q4 2019 Feb 04, 2020	SELL	$3.07 - $5.11 $104 - $173	-34 Reduced 1.56%	2,148 $12,000
Q3 2019 Nov 12, 2019	BUY	$3.29 - $8.24 $7,178 - $17,979	2,182 New	2,182 $8,000

171

44.3M

1.55M

1.52M

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $704M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.